RecruitingPhase 1 / Phase 2NCT04065399
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Sponsor: Syndax Pharmaceuticals
Sarasota, FL · Tampa, FL · +20 more sites
5 recruiting leukemia studies with a site in Sarasota, FL.
Sponsor: Syndax Pharmaceuticals
Sarasota, FL · Tampa, FL · +20 more sites
Sponsor: Nurix Therapeutics, Inc.
Coral Gables, FL · Sarasota, FL · +25 more sites
Sponsor: Nurix Therapeutics, Inc.
Miami, FL · Sarasota, FL · +16 more sites
Sponsor: Eli Lilly and Company
Jacksonville, FL · Miami, FL · Sarasota, FL · +17 more sites
Sponsor: Accutar Biotechnology Inc
Sarasota, FL · +8 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.